(NASDAQ: ANGO) Angiodynamics's forecast annual revenue growth rate of 3.77% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.53%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.15%.
Angiodynamics's revenue in 2026 is $325,378,000.On average, 6 Wall Street analysts forecast ANGO's revenue for 2027 to be $14,496,168,915, with the lowest ANGO revenue forecast at $13,888,902,657, and the highest ANGO revenue forecast at $14,943,628,263. On average, 6 Wall Street analysts forecast ANGO's revenue for 2028 to be $15,242,214,858, with the lowest ANGO revenue forecast at $14,507,103,072, and the highest ANGO revenue forecast at $15,896,582,100.
In 2029, ANGO is forecast to generate $15,782,614,541 in revenue, with the lowest revenue forecast at $14,995,775,781 and the highest revenue forecast at $16,426,468,170.